ArticleNucleic acids research2025
Solution structure of the Sox2 DNA-binding domain reveals conformational selection in DNA binding.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The transcription factor Sox2 is a master regulator of cell pluripotency. While structural studies have provided insights into its DNA-bound conformation, the mechanisms governing its free-state conformational dynamics and DNA recognition remain elusive. Based on solution NMR spectroscopy and supported by molecular dynamics simulations, we here report the solution structure of the Sox2 DNA-binding domain (DBD), revealing that its helical core is well-structured and arranged as in its DNA-bound state. The folded, free protein coexists in dynamic equilibrium with partially unfolded states, which are quenched upon specific DNA binding. We show that the electrostatic environment significantly influences the Sox2-DBD stability, with high ionic strength stabilizing the protein. NMR titration experiments demonstrate that the nonspecific and specific DNA binding interfaces of Sox2 largely overlap. Specific binding, however, uniquely involves rigidification of part of the C-terminal tail. Based on these findings, we propose that the helical core of the Sox2-DBD is stabilized in its DNA-bound form prior to binding. Binding of Sox2 to DNA thus involves conformational selection, rather than exclusively induced fit, as was previously proposed. Through its pre-folded, DNA-binding competent fold, Sox2 may be able to rapidly switch from scanning of DNA to specific binding of its cognate site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.